These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 37152961)
21. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901 [TBL] [Abstract][Full Text] [Related]
22. New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma. Taïeb D; Pacak K Trends Endocrinol Metab; 2017 Nov; 28(11):807-817. PubMed ID: 28867159 [TBL] [Abstract][Full Text] [Related]
23. Composite paraganglioma-ganglioneuroma with atypical catecholamine profile and phenylethanolamine N-methyltransferase expression: a case report and literature review. Sasaki Y; Kanzawa M; Yamamoto M; Kanie K; Bando H; Yoshino K; Hirota Y; Shigemura K; Fujisawa M; Ogawa W; Fukuoka H Endocr J; 2024 Jan; 71(1):65-74. PubMed ID: 37952980 [TBL] [Abstract][Full Text] [Related]
24. Pheochromocytomas and Paragangliomas. Tevosian SG; Ghayee HK Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773 [TBL] [Abstract][Full Text] [Related]
25. Seventy years of pheochromocytomas and paragangliomas in Argentina. The FRENAR database. de Miguel VC; Aparicio LS; Sansó G; Paissan AL; Lupi SN; Belli SH; Tkatch J; Marín MJ; Barontini MB Hipertens Riesgo Vasc; 2024; 41(3):170-178. PubMed ID: 38693013 [TBL] [Abstract][Full Text] [Related]
26. Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures. Wang K; Schober L; Fischer A; Bechmann N; Maurer J; Peischer L; Reul A; Hantel C; Reincke M; Beuschlein F; Robledo M; Mohr H; Pellegata NS; Schilbach K; Knösel T; Ilmer M; Angele M; Kroiss M; Maccio U; Broglie-Däppen M; Vetter D; Lehmann K; Pacak K; Grossman AB; Auernhammer CJ; Zitzmann K; Nölting S J Clin Endocrinol Metab; 2024 Oct; 109(11):2892-2904. PubMed ID: 38605427 [TBL] [Abstract][Full Text] [Related]
27. [Phaeochromocytoma and paraganglioma]. Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938 [TBL] [Abstract][Full Text] [Related]
28. Management of Abdominal Paraganglioma: A Single Center's Experience. Battistella E; Pomba L; Mirabella M; Toniato R; Opocher G; Toniato A Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674250 [No Abstract] [Full Text] [Related]
29. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder? Fishbein L Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972 [TBL] [Abstract][Full Text] [Related]
30. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines]. Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788 [TBL] [Abstract][Full Text] [Related]
32. Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma. Berends AMA; Kerstens MN; Lenders JWM; Timmers HJLM J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32726444 [TBL] [Abstract][Full Text] [Related]
33. [Diagnostic approach of pheochromocytomas and paragangliomas]. Gómez RM; Hernaiz M; de Miguel V; Aparicio LS; Marín MJ; Lupi S; Barontini M; Hipertens Riesgo Vasc; 2019; 36(1):34-43. PubMed ID: 30078655 [TBL] [Abstract][Full Text] [Related]
34. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism. Tevosian SG; Ghayee HK J Clin Endocrinol Metab; 2018 May; 103(5):1779-1789. PubMed ID: 29409060 [TBL] [Abstract][Full Text] [Related]
35. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990 [TBL] [Abstract][Full Text] [Related]
36. Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry. Juhlin CC Endocr Pathol; 2021 Jun; 32(2):228-244. PubMed ID: 33768452 [TBL] [Abstract][Full Text] [Related]
37. Rethinking pheochromocytomas and paragangliomas from a genomic perspective. Castro-Vega LJ; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Favier J Oncogene; 2016 Mar; 35(9):1080-9. PubMed ID: 26028031 [TBL] [Abstract][Full Text] [Related]